All Resources

Access to Medicine • May 06, 2025

Canadian Drug Access Pathway

Learn more | View

Access to Medicine • March 10, 2025

Increasing Access to Innovative Medicines

Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget…

Learn more | View

Pharmacare • May 23, 2024

IMC Submission to the Standing Committee of Health on Bill C-64

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • January 04, 2024

IMC Response to the PMPRB’s 2023 Scoping Paper for the Consultations on the Board’s Guidelines

Learn more | View

Access to Medicine • August 21, 2023

pCPA Temporary Access Process: Innovative Medicines Industry Consultation Response

Learn more | View

June 08, 2023

Submission for the parliamentary consultations on Bill 15—An Act to Make the Health and Social Services more effective

Learn more | View

Pharmacare • June 01, 2023

Addendum to Innovative Medicines Canada Submission on National Pharmacare

Learn more | View

March 08, 2023

Ontario PreBudget Submission

Learn more | View

Access to Medicine • February 15, 2023

Increasing Access to Innovative Medicines

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • December 05, 2022

The Suspension and Reformulation of the PMPRB Guidelines is Urgently Required: IMC Response to PMPRB 2022 Guidelines Proposals

Learn more | View

Access to Medicine • November 17, 2022

Innovative Agreements Framework

…describes innovative agreements being used in jurisdictions outside Canada. We prepared it to guide discussions with the pCPA Governing Council on the merits of jointly developing an innovative agreements framework….

Learn more | View

Economic Impact • October 07, 2022

Pre-Budget Consultations in Advance of the 2023 Budget

Learn more | View